home / stock / rtrx / rtrx short
Short Information | Travere Therapeutics (NASDAQ:RTRX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 763,263 |
Total Actual Volume | 6,704,252 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 38,163 |
Average Short Percentage | 11.29% |
Is there a RTRX Short Squeeze or Breakout about to happen?
See the RTRX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-18-2020 | $24.57 | $24.24 | $24.74 | $24.04 | 378,991 | 104,160 | 27.48% |
11-17-2020 | $23.98 | $24.36 | $24.57 | $23.71 | 453,146 | 82,281 | 18.16% |
11-16-2020 | $23.94 | $24.11 | $24.59 | $23.68 | 409,952 | 108,201 | 26.39% |
11-13-2020 | $23.81 | $23.68 | $24.44 | $23.33 | 289,237 | 29,188 | 10.09% |
11-12-2020 | $23.8 | $23.53 | $24.54 | $23.41 | 193,493 | 19,147 | 9.9% |
11-11-2020 | $23.86 | $24 | $24.96 | $23.56 | 294,407 | 20,331 | 6.91% |
11-10-2020 | $22.79 | $23.66 | $23.83 | $22.63 | 537,704 | 24,589 | 4.57% |
11-09-2020 | $22.24 | $22.66 | $23.325 | $21.36 | 474,296 | 41,165 | 8.68% |
11-06-2020 | $22.28 | $21.57 | $23.69 | $21.39 | 609,555 | 46,367 | 7.61% |
11-05-2020 | $21.26 | $20.89 | $21.45 | $20.65 | 226,871 | 10,637 | 4.69% |
11-04-2020 | $20.74 | $21.24 | $22.49 | $20.4644 | 469,166 | 16,790 | 3.58% |
11-03-2020 | $20.43 | $20.74 | $20.91 | $19.94 | 374,132 | 9,939 | 2.66% |
11-02-2020 | $20.48 | $20.15 | $20.58 | $19.52 | 247,693 | 34,451 | 13.91% |
10-30-2020 | $20.76 | $20.24 | $20.79 | $19.83 | 229,337 | 18,548 | 8.09% |
10-29-2020 | $20.96 | $20.78 | $21.02 | $20.42 | 138,488 | 13,140 | 9.49% |
10-28-2020 | $21.19 | $21.02 | $21.36 | $20.8 | 270,892 | 30,858 | 11.39% |
10-27-2020 | $20.99 | $21.51 | $21.58 | $20.61 | 207,508 | 18,674 | 9% |
10-26-2020 | $20.74 | $21 | $21.3 | $20.55 | 247,424 | 34,445 | 13.92% |
10-23-2020 | $21.48 | $20.95 | $21.48 | $19.53 | 405,474 | 72,356 | 17.84% |
10-22-2020 | $20.7 | $21.08 | $21.46 | $20.555 | 246,486 | 27,996 | 11.36% |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) today announced completion of patient enrollment in the Phase 3 DUPLEX Study. The pivotal DUPLEX Study is evaluating the safety and efficacy of sparsentan for the treatment of focal segmental glomerulosclerosis...
New name reflects dedication to patient- inspired mission of identifying, developing and delivering life-changing rare disease therapies Company’s s hares to t rade u nder n ew t icker s ymbol TVTX on Novem...
SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced the completion of its previously announced acquisition of Orphan Technologies Limited, a privately held, clinical-stage biopharmaceutical company focused on the development of product candidate OT-58...